Welcome our New Distributor for the UK
[…]
Category: News
From informative technical notes and project updates to new product presentations and meeting opportunities – find it all in Xell’s news section
Maximizing process yields: Trust Xell with our ideal combination of R&D services!
High-performance cell culture media for the production of monoclonal antibodies – and vaccines or viral vectors for gene therapy applications especially – are more relevant than ever. One efficient approach to increase process yields is to select the most suitable medium – or even better, to utilize a completely customized medium. By leveraging Xell’s long-standing […]
Meet our new Chinese Distributor
[…]
Sharing our secret for highest customer satisfaction with you:
[…]
The journey to AAV production in suspension: Scale up your process
Adeno-Associated Viral vectors (AAV) are among the most widely used vectors for gene therapy applications and their importance has become even more evident recently. To support you in your process scale-up, we address questions like “Why should you consider transferring your AAV production from adherent to suspension?” and discuss different case studies (AAV-2 and AAV-8) […]
The key to an easier scale-up: Suspension-adapted cells
Traditional mammalian cell culture is usually anchor-dependent and serum-supplemented, which is directly connected to a series of disadvantages, due to the serum/ animal derived components. In contrast, suspension cultures in animal-derived component free (ADCF) cell culture media have several advantages: reduced lot-to-lot variability of the medium easier scale-up no risk of blood-borne pathogens massively reduced […]
We are attending BIO Digital 2021
[…]
Keeping your project on time and up-to-date with Xell’s transparent ordering process
Have your liquid or dry powder production requirements fulfilled by our dedicated teams of experts: Transform your ideas into high-performance materials with the support of our product engineers Reliable lead times guaranteed by our manufacturing team Material compliance through continuous examination carried out by our analytical department Get the documentation you need to meet your […]
Xell at Bio-Europe Spring 2021 | Delivered Digitally
[…]
The highest quality and shortest response times – Xell’s powder production
Tap into the resources provided by our state-of-the-art dry powder line: 100% animal origin-free (AOF) production Flexibility with batch and packaging sizes Customization to meet your project requirements Scalability; from prototype 1 kg/batch to 1,000 kg/batch (≈ 40,000 – 50,000 L medium) A capable team of engineers and scientists, at your disposal Transparent process steps […]
